ISA 201

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameISA 201
Drug Alias NameHespectaHPV16 E6 Peptide Conjugated To AMPLIVANTHPV E-Six Peptide Conjugated To AMPLIVANTISA-201
ClassificationVaccines > Development/production technology > Synthetic peptide vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHead and Neck NeoplasmsPapillomavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesIsa Pharmaceuticals Bv
China Registration ClassN/A

Develop Information

Active CompaniesIsa Pharmaceuticals Bv
Inactive CompaniesN/A
Active IndicationsHead and Neck NeoplasmsPapillomavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A